Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial - Quiz - MDSpire

Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial

  • By

  • Sebastian Wolf

  • Youxin Chen

  • Xiaorong Li

  • Masahiko Shimura

  • Taiji Sakamoto

  • Charles C. Wykoff

  • Andres Emanuelli

  • Hani Salehi-Had

  • Kang Yan

  • Lidija Kovacic

  • Yongsoo Kim

  • June 1, 2026

  • 0 min

Share

Original Source(s)

Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial

  • by Sebastian Wolf, Youxin Chen, Xiaorong Li, Masahiko Shimura, Taiji Sakamoto, Charles C. Wykoff, Andres Emanuelli, Hani Salehi-Had, Kang Yan, Lidija Kovacic, Yongsoo Kim

  • June 1, 2026

Related Content

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

The difference in scotopic and photopic pupil responses: a potential indicator for long-term glycemic management

Editorial: Community series in: clinical and genetic determinants of diabetes and complications, volume II